MTOR and infectious disease: Better seizure control and delayed decline in lung function were reported with mTOR inhibitors use in patients with symptomatic cortical tuber and pulmonary LAM, respectively.[7–11] Diseases of genetic origin are given less emphasis in sub-Saharan Africa and managed as low-priority cases as overburdened by infectious diseases.